EMEA-001268-PIP01-12-M05

Key facts

Invented name
Repatha
Active substance
Evolocumab
Therapeutic area
Cardiovascular diseases
Decision number
P/0104/2018
PIP number
EMEA-001268-PIP01-12-M05
Pharmaceutical form(s)
Solution for injection
Condition(s) / indication(s)
  • Treatment of mixed dyslipidaemia
  • Treatment of elevated cholesterol
Route(s) of administration
Subcutaneous use
Contact for public enquiries
Amgen Europe B.V
Tel. +44 (0)1223 420305
E-mail: medinfointernational@amgen.com
Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating